Faithward Advisors’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $82.6K | Buy |
+14,420
| New | +$82.6K | 0.01% | 263 |
|
|
2024
Q3 | – | Sell |
-281,659
| Closed | -$2.79M | – | 283 |
|
|
2024
Q2 | $2.79M | Buy |
281,659
+8,151
| +3% | +$80.9K | 0.51% | 61 |
|
|
2024
Q1 | $3.22M | Buy |
273,508
+2,515
| +0.9% | +$29.6K | 0.58% | 53 |
|
|
2023
Q4 | $3.44M | Sell |
270,993
-1,180
| -0.4% | -$15K | 0.76% | 40 |
|
|
2023
Q3 | $2.8M | Sell |
272,173
-6,488
| -2% | -$66.6K | 0.68% | 44 |
|
|
2023
Q2 | $3.74M | Sell |
278,661
-8,389
| -3% | -$113K | 0.86% | 32 |
|
|
2023
Q1 | $3.35M | Sell |
287,050
-28,756
| -9% | -$336K | 0.76% | 35 |
|
|
2022
Q4 | $3.86M | Sell |
315,806
-413
| -0.1% | -$5.04K | 0.84% | 40 |
|
|
2022
Q3 | $3.3M | Buy |
+316,219
| New | +$3.3M | 0.78% | 41 |
|